{"id":"W2264705762","doi":"10.1016/s1474-4422(16)00018-1","title":"Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Sphingosine-1-phosphate receptor; Placebo; Medicine; Sphingosine-1-phosphate; Internal medicine; Pharmacology; Receptor; Sphingosine; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001645819,0.0002669015,0.001392809,0.0001110307,0.0002122101,0.00001267549,0.0003165688,0.0001364045,0.00005198955],"category_scores_gemma":[0.007948638,0.0001224713,0.0002033338,0.0003559346,0.0006682494,0.00007849972,0.0002167908,0.0005346591,0.000008352398],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007116628,"about_ca_system_score_gemma":0.0001026865,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001139354,"about_ca_topic_score_gemma":0.0001240407,"domain_scores_codex":[0.9968649,0.001008594,0.0006603885,0.0004856773,0.0003374795,0.0006429295],"domain_scores_gemma":[0.9940038,0.00481229,0.0003169142,0.0006424917,0.0001127488,0.0001117277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8981292,0.0003210556,0.00522565,0.00002495062,0.0002083336,0.000004189004,0.0005376072,0.00004148983,0.08261118,0.00004491857,0.0006725847,0.01217885],"study_design_scores_gemma":[0.9232464,0.001358604,0.06685337,0.0001966884,0.00009717423,0.00001158544,0.00001547045,0.002162706,0.00468115,0.0000477394,0.001197199,0.0001319524],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9706315,0.0007838341,0.00007563632,0.02295638,0.0003869288,0.004870252,0.00005023668,0.00004308769,0.0002021],"genre_scores_gemma":[0.9954428,0.00279443,0.00007715193,0.0007643999,0.0005119136,0.0002613393,0.000001774422,0.00003586325,0.0001103374],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07793003,"threshold_uncertainty_score":0.9515836,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04882834581778473,"score_gpt":0.3012512679795377,"score_spread":0.252422922161753,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}